Added to YB: 2025-01-28
Pitch date: 2025-01-26
ICAD [bullish]
iCAD, Inc.
+54.8%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy.
Market Cap
$47.6M
Pitch Price
$2.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.90
P/E
-8.21
EV/Sales
1.57
Sector
Health Care Technology
Category
turnaround
Show full summary:
iCAD, Inc. - $ICAD
ICAD: Legacy mammography firm pivoting to SaaS/DaaS model. Short-term revenue drop, increased OpEx as ARR grows (10.7% YoY, subscription 57% YoY). Cash-rich, minimal debt. Profitability delayed to Q3 2026. Global partnerships expanding. 50% downside risk, upside potential unclear.
Read full article (11 min)